Physician Perspectives on the Diagnosis and Management of Heart Failure With Preserved Ejection Fraction
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Amgen
- Sanofi
- Novo Nordisk
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Bausch Health
- AstraZeneca
- Janssen Pharmaceutica
- HLS Therapeutics
- Bayer
- Novartis Pharmaceuticals Canada
- Cytokinetics
- Novartis
- American Regent
- Merck
This publication has 29 references indexed in Scilit:
- Clinical Practices and Attitudes Regarding the Diagnosis and Management of Heart Failure: Findings from the CORE Needs Assessment SurveyESC Heart Failure, 2017
- The Impact of CME on Physician Performance and Patient Health Outcomes: An Updated Synthesis of Systematic ReviewsJournal of Continuing Education in the Health Professions, 2015
- Spironolactone for Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2014
- “It’s Somebody else’s responsibility”- perceptions of general practitioners, heart failure nurses, care home staff, and residents towards heart failure diagnosis and management for older people in long-term care: a qualitative interview studyBMC Geriatrics, 2013
- Epidemiology and risk profile of heart failureNature Reviews Cardiology, 2010
- Consultation with cardiologists for persons with new-onset chronic heart failure: A population-based studyCanadian Journal of Cardiology, 2009
- Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: Data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registryCanadian Journal of Cardiology, 2009
- Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based StudyNew England Journal of Medicine, 2006
- An overview of the types of physicians treating acute cardiac conditions in Canada.2004
- Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative studyBMJ, 2003